rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2004-12-15
|
pubmed:abstractText |
We recently showed that the levels of secreted human leukocyte antigen-G (HLA-G), a nonclassical MHC class I antigen, are significantly elevated in malignant effusions in ovarian carcinoma compared to benign ones. The objective of this study was to evaluate the expression and clinical role of HLA-G in effusions and corresponding solid tumors from patients diagnosed with advanced-stage ovarian carcinoma.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0090-8258
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
42-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15589578-Adult,
pubmed-meshheading:15589578-Aged,
pubmed-meshheading:15589578-Aged, 80 and over,
pubmed-meshheading:15589578-Antibodies, Monoclonal,
pubmed-meshheading:15589578-Ascitic Fluid,
pubmed-meshheading:15589578-Female,
pubmed-meshheading:15589578-HLA Antigens,
pubmed-meshheading:15589578-HLA-G Antigens,
pubmed-meshheading:15589578-Histocompatibility Antigens Class I,
pubmed-meshheading:15589578-Humans,
pubmed-meshheading:15589578-Immunohistochemistry,
pubmed-meshheading:15589578-Middle Aged,
pubmed-meshheading:15589578-Neoplasm Metastasis,
pubmed-meshheading:15589578-Neoplasm Staging,
pubmed-meshheading:15589578-Ovarian Neoplasms,
pubmed-meshheading:15589578-Pleural Effusion,
pubmed-meshheading:15589578-Prognosis,
pubmed-meshheading:15589578-Tumor Markers, Biological
|
pubmed:year |
2005
|
pubmed:articleTitle |
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
|
pubmed:affiliation |
Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Montebello N-0310 Oslo, Norway. bend@ulrik.uio.no
|
pubmed:publicationType |
Journal Article
|